Dr. Phil Lowe
Phil is an experienced pharmacometrician with 30+ years working within Pharma. His expertise centres on applying PKPD model-based analyses to preclinical and clinical data in order to select appropriate posologies to study, as well as for market licence applications and updates thereof. Prior to becoming an industry consultant he was Executive Director in Pharmacometrics at Novartis, leading the strategic direction of the development and application of pharmacometric methodologies to R&D projects.
Dr Jennifer Sims
More than 25 years’ experience in the specialist biotech and global Pharma, and UK/European regulatory agencies. Prior to becoming an independent consultant in 2012, Jenny was Head of Translational Sciences & Safety for Novartis Biologics. She specializes in integrated non-clinical development, including safety assessment, translational PK-PD, immunogenicity risk assessments and regulatory strategies for biopharmaceuticals and advanced therapeutic products.